Time	Session	Speaker
09:00-09:10	Opening Remarks		Eun Sook Lee, M.D., Ph.D. (President, NCC)
Session 1	Multilateral Strategy for Precision Oncology [KOR-USA WebEx Symposium] (Language: 영어)		Chair: Sang Jae Park, M.D., Ph.D. (Director of Research Institute, NCC)
09:10-09:25 (15 mins)	Proteo-genomics Project in NCC	Jong Bae Park, Ph.D. (Dean of NCC-GCSP, NCC)
09:20-10:10 (50 mins)	From Germline Genetics to Function: Making Sense of Genome-Wide Association Studies for Pancreatic Cancer Risk	Laufey Amundadottir, M.D., Ph.D. (NCI, USA)
10:10-10:55 (45 mins)	Overview of NCI Core Facility System & Proteomics Study	Thorkell Andresson, M.D., Ph.D. (NCI, USA)
10:55-11:00 (5 min)	Closing
11:30-13:00	Lunch
Session 2	Advanced Technology for Omics-Informed Biomarker Discovery (Language: 한국어)	Chair: Sang Myung Woo, M.D., Ph.D. (Chief, Biomedicine Production Branch, NCC)
13:00-13:40 (40 mins)	Cancer Study Using Public Omics Big Data	Dong Wan Hong, Ph.D. (Chief, Clinical Genomic Analysis Branch, NCC)
13:40-14:10 (30 mins)	Genomics	Charles C. Chung, M.D., Ph.D. (NCI, USA)
14:10-14:50	NGS-based Approaches for Cancer Genomics	Dong Hyun Park, M.D., Ph.D. (Chief Researcher, Samsung Genome Institute, Samsung Medical Center, Korea)
14:50-15:20	Break Time
15:20-16:00	Next-generation Proteomic Pipeline with LC-MS/MS and Customized Databases: Application for Breast Cancer Research	Hee Youn Hwang, M.D., Ph.D. (Senior Research Fellow, Biomedical Omics Group, Korea Basic Science Institute, Korea)
16:00-16:40	Proteometabolomic Approach To Develop Prediction Model for Therapeutic Outcomes Before And After PD-1 Pathway Blocking Cancer Immunotherapy	Byong Chul Yoo, Ph.D. (Chief Scientist, Biomarker Branch, Division of Translational Science, NCC)
16:40-17:30 (50 mins)	Panel Discussion
17:30	Closing Remarks

※Session 2는 한국어로 진행됩니다.